GlassScriptPhysician profile
Howard I Siegel
NPI 1104836337
$4,355.95
in general payments reported to CMS, 2019-2025
35 companies · $825 in 2025
The $825 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2020: $510 · 2021: $349 · 2022: $728 · 2023: $695 · 2024: $745 · 2025: $825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,264.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $610.15 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $460.04 | 2019-2023 | Trulance, Xifaxan |
| Abbvie INC. | $410.31 | 2019-2025 | Ubrelvy |
| Merck Sharp & Dohme LLC | $305.71 | 2019-2024 | Dificid |
| Lilly USA, LLC | $290.85 | 2020-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $263.26 | 2021-2025 | Jardiance |
| Viiv Healthcare Company | $256.23 | 2024-2025 | Apretude |
| Intercept Pharmaceuticals, INC. | $211.26 | 2019-2025 | |
| Gilead Sciences, INC. | $207.91 | 2019-2025 | |
| Intra-Sana Laboratories | $163.98 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Daiichi Sankyo INC. | $117.71 | 2020-2022 | |
| Astellas Pharma US INC | $113.40 | 2025 | Veozah |
| Amgen INC. | $112.80 | 2019-2025 | Tavneos |
| Phathom Pharmaceuticals, INC. | $102.31 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $70.33 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $60.60 | 2019-2023 | |
| Hologic Sales and Service, LLC | $58.86 | 2024 | Aptima |
| Scilex Pharmaceuticals INC. | $57.89 | 2019-2021 | |
| Glaxosmithkline, LLC. | $56.87 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $54.01 | 2019-2023 | Nascobal |
| Allergan, INC. | $51.45 | 2019 | |
| Incyte Corporation | $44.64 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.06 | 2020-2021 | |
| Currax Pharmaceuticals LLC | $30.01 | 2024 | Contrave |
| Astrazeneca Pharmaceuticals LP | $24.00 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $23.46 | 2025 | Iqirvo |
| Medicomp INC | $23.38 | 2025 | Telepatch Cardiac Monitor |
| Janssen Biotech, INC. | $21.09 | 2022 | |
| Novum Pharma, LLC | $20.32 | 2019 | |
| Phadia US INC. | $20.11 | 2025 | Immunocap |
| Boston Scientific Corporation | $17.42 | 2022 | |
| Therapeuticsmd, INC. | $16.80 | 2020 | |
| Genentech USA, INC. | $16.50 | 2020 | |
| Bausch Health US, LLC | $16.36 | 2020 | |
| Linus Health, INC. | $15.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Siegel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.